Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease
Benefits of Ambulatory Oxygen in Hypoxemic COPD Patients
Sponsor: Chronic Obstructive Pulmonary Disease Clinical Research Network
Terminated
low recruitment
Other Pulmonary Disease, Chronic Obstructive trials with similar outcome
Listed as NCT00325754, this NA trial focuses on Pulmonary Disease, Chronic Obstructive and remains terminated or withdrawn. Sponsored by Chronic Obstructive Pulmonary Disease Clinical Research Network, it has been updated 9 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Dec 2019 — Jan 2021 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Nov 2019 — Dec 2019 [monthly]
Terminated NA
-
Jun 2018 — Nov 2019 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Mar 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chronic Obstructive Pulmonary Disease Clinical Research Network
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .